Recent articles
These 2 Stocks Could Be 2020's Best Profit Opportunities
How do we find the top stock of 2020? The best performers in 2019 offer some clues.
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
A host of major healthcare companies and drug retailers are collaborating on a system to combat fake drugs.
Anika Therapeutics Beats Revenue and Earnings Estimates
A recent acquisition and a new product launch held back earnings, but should be beneficial over the long term.
3 High-Growth Stocks Whose Gains Are Just Getting Started
These young companies have already delivered big returns for their shareholders, and there's every reason to expect more to come.
Vir Bio Identifies 2 Antibodies That Might Stop Coronavirus
Antibody-based treatments can be used both to protect people from infection and to treat those already affected.
Ionis Receives Orphan Drug Designation From EMA
The company is advancing a new treatment for people with Alexander disease.
Myriad Genetics CEO Mark Capone Resigns
The molecular diagnostics company also delivered an earnings miss, and its stock plunged.
Alnylam Beats Revenue Estimates, but Misses on Earnings
Shares of the genetic disease specialist were essentially flat in late afternoon trading.
Abiomed Crushed Its Earnings Estimates, but the Market Wasn't Impressed
The medical device maker's stock dropped 9%, then recovered.
3 Top Small-Cap Stocks to Buy in February
An insurance-shopping portal, a U.K. software company, and a Brazilian medical school operator all have potential for outsize returns.
Why Did Karuna Therapeutics Pop 26% in January?
The volatile biotech has been up and down since its massive gain back in November.
2 Top Healthcare Stocks to Buy Right Now
These two biotechs have major drugs that should be hitting the market soon.
Why Sea Stock Was Up 12.5% in January
The Singapore internet giant might be entering the banking business.
Why Is Microsoft Investing in Adaptive Biotechnologies?
The two companies hope to decode the human immune system.
World Health Organization Classifies Wuhan Coronavirus as International Health Emergency
Around 99% of cases are in China.
Aprea Therapeutics Receives Breakthrough Therapy Designation for APR-246
The drug candidate is in phase 3 trials as a treatment of myelodysplastic syndrome (MDS), which often leads to blood and bone marrow cancers.
3 Top Stocks Under $20
Right now you can buy an interstellar airline, a vaccine specialist, and an oil tanker company -- all on sale.
The Best Cannabis Stock for the Next 10 Years
Federal regulations are stifling the industry, and one company is taking advantage.
Horizon Therapeutics Gets FDA Approval for Eye Drug
First FDA-approved medicine for thyroid eye disease.
At Davos, Alphabet's CEO Calls Healthcare the Major AI Opportunity
The tech giant wants to bring artificial intelligence to bear on solving diseases like cancer, but the side effect of that could be a loss of our privacy.